Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

25%

5 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (9)
P 1 (1)
P 3 (1)
P 4 (4)

Trial Status

Completed8
Unknown6
Withdrawn3
Recruiting3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT01692873Not ApplicableCompletedPrimary

Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors

NCT05871164RecruitingPrimary

Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency

NCT04075305Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

NCT06641947CompletedPrimary

Differentiation Benign and Malignant Pancreatic Lesions

NCT03340844Not ApplicableCompletedPrimary

Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors

NCT01673334Phase 4CompletedPrimary

Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine-needle Aspiration for Suspected Pancreatic Neoplasms

NCT05794048Not ApplicableRecruiting

METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors

NCT03558945Phase 1UnknownPrimary

Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor

NCT02716207Not ApplicableCompletedPrimary

Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife

NCT04357483Phase 4UnknownPrimary

Effect of Thrombin-containing Collagen-based Hemostatic Matrix

NCT02330497Not ApplicableCompletedPrimary

Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor

NCT03444051CompletedPrimary

Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors

NCT01434550Not ApplicableWithdrawnPrimary

Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer

NCT02534246Not ApplicableWithdrawnPrimary

Head to Head Comparison of Two Needles EUS Guided FNB

NCT02269683Not ApplicableWithdrawnPrimary

Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer

NCT01698190Not ApplicableUnknownPrimary

Comparing the Efficacy of Endoscopic FNA vs FNB in Diagnosing Solid Gastrointestinal Lesions

NCT01479803Phase 3CompletedPrimary

Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS

NCT01978808UnknownPrimary

Efficiency Study of the EUS-FNA Needles With and Without a Side Port in Pancreatic Masses

NCT01969110Phase 4UnknownPrimary

Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

NCT01819961Phase 4Unknown

Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery

Showing all 20 trials

Research Network

Activity Timeline